NF-κB regulation: the nuclear response

被引:142
|
作者
Mankan, Arun K.
Lawless, Matthew W.
Gray, Steven G.
Kelleher, Dermot
McManus, Ross
机构
[1] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland
[2] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland
基金
英国惠康基金; 爱尔兰科学基金会;
关键词
NF-kappa B; inflammation; nuclear regulation; immunity; cancer; ZINC-FINGER PROTEIN; TRANSCRIPTION FACTOR; DNA-BINDING; HISTONE DEACETYLASES; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; GENE-EXPRESSION; BCL-3; PHOSPHORYLATION; DEGRADATION;
D O I
10.1111/j.1582-4934.2009.00632.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction Activation of NF-B-kappa Regulators of NF-B-kappa activation Nuclear regulation of NF-kappa B B cell lymphoma 3 (Bcl-3) I kappa B-zeta UXT, ZAS3 and PDLIM2 Post-translational modification of NF-B-kappa complex in the nucleus Phosphorylation Acetylation and Deacetylation Sumoylation Nuclear regulators of NF-kappa B: potential molecular chaperones Conclusion Nuclear factor kappa B (NF-kappa B) is an inducible transcription factor that tightly regulates the expression of a large cohort of genes. As a key component of the cellular machinery NF-kappa B is involved in a wide range of biological processes including innate and adaptive immunity, inflammation, cellular stress responses, cell adhesion, apoptosis and proliferation. Appropriate regulation of NF-kappa B is critical for the proper function and survival of the cell. Aberrant NF-kappa B activity has now been implicated in the pathogenesis of several diseases ranging from inflammatory bowel disease to autoimmune conditions such as rheumatoid arthritis. Systems governing NF-kappa B activity are complex and there is an increased understanding of the importance of nuclear events in regulating NF-kappa B's activities as a transcription factor. A number of novel nuclear regulators of NF-kappa B such as I kappa B-zeta and PDZ and LIM domain 2 (PDLIM2) have now been identified, adding another layer to the mechanics of NF-kappa B regulation. Further insight into the functions of these molecules raises the prospect for better understanding and rational design of therapeutics for several important diseases.
引用
收藏
页码:631 / 643
页数:13
相关论文
共 50 条
  • [1] Deubiquitinases in the regulation of NF-κB signaling
    Harhaj, Edward W.
    Dixit, Vishva M.
    CELL RESEARCH, 2011, 21 (01) : 22 - 39
  • [2] Nuclear translocation of STAT3 and NF-κB are independent of each other but NF-κB supports expression and activation of STAT3
    Martincuks, Antons
    Andryka, Katarzyna
    kuester, Andrea
    Schmitz-Van de Leur, Hildegard
    Komorowski, Michal
    Mueller-Newen, Gerhard
    CELLULAR SIGNALLING, 2017, 32 : 36 - 47
  • [3] Regulation of NF-κB activity by competition between RelA acetylation and ubiquitination
    Li, H.
    Wittwer, T.
    Weber, A.
    Schneider, H.
    Moreno, R.
    Maine, G. N.
    Kracht, M.
    Schmitz, M. L.
    Burstein, E.
    ONCOGENE, 2012, 31 (05) : 611 - 623
  • [4] The IκB kinase complex in NF-κB regulation and beyond
    Hinz, Michael
    Scheidereit, Claus
    EMBO REPORTS, 2014, 15 (01) : 46 - 61
  • [5] Selectivity of the NF-κB Response
    Sen, Ranjan
    Smale, Stephen T.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (04): : a000257
  • [6] The Regulation of NF-κB Subunits by Phosphorylation
    Christian, Frank
    Smith, Emma L.
    Carmody, Ruaidhri J.
    CELLS, 2016, 5 (01)
  • [7] Mutual regulation of metabolic processes and proinflammatory NF-κB signaling
    Kracht, Michael
    Mueller-Ladner, Ulf
    Schmitz, M. Lienhard
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (04) : 694 - 705
  • [8] Regulation of NF-κB induction by TCR/CD28
    Cheng, Jing
    Montecalvo, Angela
    Kane, Lawrence P.
    IMMUNOLOGIC RESEARCH, 2011, 50 (2-3) : 113 - 117
  • [9] NF-κB signaling in inflammation and cancer
    Zhang, Tao
    Ma, Chao
    Zhang, Zhiqiang
    Zhang, Huiyuan
    Hu, Hongbo
    MEDCOMM, 2021, 2 (04): : 618 - 653
  • [10] To be, or not to be:: NF-κB is the answer -: role of Rel/NF-κB in the regulation of apoptosis
    Kucharczak, J
    Simmons, MJ
    Fan, YJ
    Gélinas, C
    ONCOGENE, 2003, 22 (56) : 8961 - 8982